Related by context. All words. (Click for frequent words.) 73 anticoagulation therapy 72 warfarin therapy 69 oral anticoagulation 69 antiplatelet therapy 68 anticoagulant therapy 67 eptifibatide 67 antithrombotic therapy 66 LMWH 66 unfractionated heparin 66 thrombolytic therapy 65 fibrinolytic therapy 65 rt PA 65 tirofiban 65 warfarin 64 lipid lowering therapy 64 fondaparinux 64 statin therapy 64 DAPT 64 coronary revascularization 64 PRADAXA 64 β blockers 64 reperfusion therapy 64 thromboprophylaxis 63 dual antiplatelet therapy 63 antiarrhythmic drug 63 periprocedural 63 nonoperative 63 ICD implantation 63 oral anticoagulant therapy 63 thromboembolic 63 warfarin anticoagulation 62 thrombolysis 62 abciximab 62 platelet reactivity 62 inotropic 62 bisphosphonate therapy 62 GP IIb IIIa inhibitors 62 revascularization procedures 62 reinfarction 62 resynchronization therapy 62 antimicrobial prophylaxis 62 ventilatory 62 enoxaparin 62 antihypertensive therapy 62 extubation 62 postoperative AF 62 coadministration 62 coronary intervention 62 alteplase 62 revascularization 62 inotropes 62 International Normalized Ratio 62 clopidogrel 61 systemic corticosteroids 61 peginterferon 61 BYSTOLIC 61 thrombolytic agents 61 beta blocker therapy 61 platelet inhibition 61 dose atorvastatin 61 thrombotic events 61 antibiotic prophylaxis 61 HbA1c levels 61 fibrinolytic 61 APTIVUS r 61 serum phosphorous 61 bolus dose 61 idraparinux 61 aldosterone antagonists 61 amiodarone 61 percutaneous intervention 60 thrombotic complications 60 antiarrhythmic drugs 60 aldosterone antagonist 60 ICD therapy 60 rFVIIa 60 endotracheal intubation 60 reperfusion 60 glycated hemoglobin levels 60 surgical revascularization 60 anticoagulants 60 antihypertensive medications 60 inhaled nitric oxide 60 pretest probability 60 intravenous diuretics 60 platelet inhibitor 60 postoperative morbidity 60 NATRECOR ® 60 upper gastrointestinal bleeding 60 GnRH agonist 60 serum phosphorus 60 elective PCI 60 oral anticoagulants 60 percutaneous coronary intervention 60 TAXUS Stent 60 antiplatelet agents 60 carotid artery stenting 60 androgen deprivation 60 cytoreductive surgery 60 electrical cardioversion 60 sotalol 60 perioperative 60 thromboembolic events 60 myocardial reperfusion 59 eplerenone 59 biventricular pacing 59 thrombolytics 59 antiplatelet medication 59 sirolimus eluting stents 59 molecular weight heparins 59 virologic failure 59 serum potassium 59 revascularisation 59 NATRECOR R 59 postoperative mortality 59 milrinone 59 VTE prophylaxis 59 VAPRISOL 59 Abciximab 59 verapamil 59 insulin detemir 59 paroxysmal AF 59 OPCAB 59 nicardipine 59 stenting 59 fibrinolysis 59 left ventricular dysfunction 59 glycemic control 59 renal function 59 inotropic therapy 59 thromboembolism 59 mealtime insulin 59 aspirin clopidogrel 59 everolimus eluting stents 59 GP IIb IIIa inhibitor 59 clopidogrel Plavix 59 hypoxemia 59 postoperative complication 59 symptomatic VTE 59 antiplatelet drugs 59 STEMI patients 59 anticoagulated 59 QTc prolongation 59 antithrombotic 59 flecainide 59 hemodynamic 59 NSAID therapy 59 patients undergoing CABG 59 acute coronary syndromes 59 ATACAND 58 antiplatelet medications 58 unfractionated heparin UFH 58 virological response 58 hypertensive patients 58 anti coagulant therapy 58 dosing 58 antidiabetic drugs 58 CABG surgery 58 glycoprotein IIb IIIa inhibitors 58 thrombus aspiration 58 EXJADE 58 tumor resection 58 bypass grafting 58 ICD shocks 58 hemorrhagic complications 58 postoperative 58 levosimendan 58 IIIa inhibitor 58 recurrent VTE 58 cardiopulmonary bypass 58 hemoglobin A1c levels 58 GnRH agonists 58 antihypertensive agents 58 coronary angiography 58 dosage regimen 58 perioperatively 58 Elitek 58 oral corticosteroids 58 TMP SMX 58 REG1 58 HSCT 58 PICSO ® 58 LVEF 58 DVT prophylaxis 58 BENICAR HCT 58 glycemia 58 D dimer 58 antithrombotic therapies 58 alpha blocker 58 cangrelor 58 anticoagulant warfarin 58 antiplatelet 58 lipid lowering drugs 58 postoperative pulmonary 58 LATUDA 58 premedication 58 recurrent ischemia 58 immunosuppressive agents 58 glucocorticoid therapy 58 adjuvant therapy 58 Hypotension 58 intracoronary 58 surrogate endpoint 58 perioperative mortality 58 UA NSTEMI 58 concomitant medications 58 treprostinil 58 immunosuppression 58 clopidogrel pretreatment 58 paricalcitol 58 tamponade 58 antiplatelet therapies 58 myocardial ischemia 58 noninferiority 58 irbesartan 58 dobutamine 58 argatroban 58 MULTAQ 58 fulvestrant 58 chemoradiotherapy 58 IOP lowering 58 peri procedural 58 hyperkalemia 58 tiotropium 58 bezafibrate 58 intravenous IV infusion 58 radioiodine therapy 58 quinidine 58 acute ischemic stroke 58 dose titration 58 NNT = 58 hemodilution 58 corticosteroid therapy 58 normothermia 58 clot dissolving drug 58 lipid lowering agents 58 cardiopulmonary bypass CPB 58 pharmacologic therapy 58 peri operative 58 procalcitonin 58 dosage regimens 58 carotid revascularization 57 echocardiographic 57 atrial arrhythmias 57 stent implantation 57 intravascular 57 postsurgical 57 bronchodilation 57 cerebrovascular events 57 postoperative pain 57 NSTE ACS 57 thoracoscopic lobectomy 57 levothyroxine 57 nonoperative treatment 57 imipenem 57 revascularization procedure 57 prehospital 57 immunosuppressant therapy 57 lispro 57 mixed hyperlipidemia 57 directed thrombolysis 57 tPA 57 systemic hypotension 57 direct thrombin inhibitors 57 angioplasty stenting 57 hemodialysis patients 57 dose statin therapy 57 stable angina 57 ventricular pacing 57 cardiac toxicity 57 adjunctive 57 postoperative radiotherapy 57 noninferior 57 ezetimibe simvastatin 57 clevidipine 57 parathyroidectomy 57 antithrombotics 57 mycophenolate mofetil 57 HAART regimens 57 nephrotoxicity 57 HbA 1c levels 57 Anticoagulation 57 FASLODEX 57 subcutaneous infusion 57 antifungal therapy 57 aspirin regimen 57 hypotensive 57 beta blocker 57 dosing frequency 57 indapamide 57 antidepressant therapy 57 Thrombolysis 57 refractory ischemia 57 nonpharmacologic 57 loop diuretics 57 opioid analgesia 57 aprotinin 57 oral anticoagulant 57 AZOR 57 PREZISTA r 57 ximelagatran 57 postoperative bleeding 57 serum sodium 57 EBRT 57 colectomy 57 PCIs 57 postprocedure 57 intravesical therapy 57 hemodynamic instability 57 systolic hypertension 57 tissue plasminogen activator tPA 57 coronary revascularization procedures 57 adjuvant radiotherapy 57 antiplatelet agent 57 CRRT 57 postoperative atrial fibrillation 57 acute coronary syndrome 57 divalproex sodium 57 stratifying patients 57 glycated hemoglobin HbA1c 57 Hydroxyurea 57 intensive statin therapy 57 tecarfarin 57 vasopressor 57 preoperative chemotherapy 57 octreotide 57 venous thromboembolism 57 recombinant tissue plasminogen 57 infarct size 57 ADHF 57 certolizumab 57 clozapine 57 decitabine 57 otamixaban 57 pharmacologic 57 DMARDs 57 decompensated heart failure 57 primary percutaneous coronary 57 prothrombin 56 comorbid conditions 56 acetazolamide 56 QTc intervals 56 anticoagulant medication 56 graft patency 56 postoperative complications 56 Percutaneous Coronary Intervention 56 bi ventricular pacing 56 DES implantation 56 inhaled corticosteroids ICS 56 cilostazol 56 inhaled corticosteroids 56 deferoxamine 56 pamidronate 56 phenytoin 56 A1c levels 56 ischemic cardiomyopathy 56 subcutaneous insulin 56 neoadjuvant chemotherapy 56 hepatic function 56 primidone 56 epoetin alfa 56 hydroxychloroquine 56 myocardial infarction 56 contrast induced nephropathy 56 nesiritide 56 transcatheter closure 56 vasodilators 56 FOLFOX4 56 endarterectomy 56 TURBT 56 cirrhotic patients 56 Afib 56 extracorporeal circulation 56 DMARD 56 Hb levels 56 anticoagulant medications 56 glucocorticoid 56 hemoglobin Hb 56 immunomodulatory therapy 56 Cypher Stent 56 DEFINITY ® 56 platelet function 56 bivalirudin 56 iodixanol 56 oral hypoglycemic agents 56 corticosteroids 56 pioglitazone 56 NPH insulin 56 Insulin PH# 56 venography 56 dose colchicine 56 immunosuppressive regimen 56 repeat revascularization 56 antihypertensive drugs 56 recurrent venous thromboembolism 56 stenoses 56 biochemical recurrence 56 β blocker 56 inotropic agents 56 postdischarge 56 intravenous cyclophosphamide 56 coronary interventions 56 carotid endarterectomy CEA 56 rehospitalization 56 carotid endarterectomy 56 paracentesis 56 drug eluting stent implantation 56 ACE inhibitor ramipril 56 amphotericin B 56 procedural sedation 56 salmeterol fluticasone 56 KAPIDEX 56 arrhythmias 56 oral rivaroxaban 56 COREG 56 paclitaxel eluting stents 56 thromboembolic complications 56 ribavirin RBV 56 tracheal intubation 56 fistula closure 56 sinus rhythm 56 chemoradiation 56 MADIT II 56 HbA 1c 56 coronary stenosis 56 antiarrhythmic 56 cardiac resynchronization 56 adalimumab 56 DMARD therapy 56 variceal bleeding 56 beta blockers 56 preoperatively 56 intravascular volume 56 parenteral nutrition 56 abacavir lamivudine 56 serum phosphate levels 56 chronic hemodialysis 56 neuromuscular blockade 56 dosing regimens 56 TAXUS Express Stent 56 anthracycline therapy 56 coronary stenting 56 pump CABG 56 hyperphosphatemia 56 acutely decompensated congestive heart 56 HbA1c 56 Hb A1C 56 asthma exacerbations 56 atherosclerotic renal artery stenosis 56 allopurinol 56 nebulization 56 intensive lipid lowering 56 virologic response 56 hemodynamics 56 tolvaptan 56 pulmonary artery banding 56 fluticasone salmeterol 56 trabeculectomy 56 renal insufficiency 56 dalteparin 56 intraoperatively 56 invasive coronary angiography 56 COPD exacerbations 56 Endarterectomy 56 CMV infection 56 cTnI 56 tinzaparin 56 atrial fibrillation AF 56 atherothrombotic events 56 thiazide diuretic 56 lipoprotein levels 56 corrected QT interval 56 Lantus R 56 fluvastatin 56 pioglitazone HCl 56 AGILECT R 56 refractory angina 56 nonadherence 56 warfarin dosage 56 tapentadol ER 56 hepatotoxicity 56 cannulation 56 sirolimus 56 dexmedetomidine 56 viral suppression 56 nonfatal MI 56 dosing interval 56 unstable angina UA 56 ARIXTRA 56 angina pectoris 56 aripiprazole 56 posttransplant 56 hypocalcemia 56 severe hypoglycemia 56 ACE inhibitor 56 ventricular arrhythmias 56 ketorolac 56 analgesic medications 56 LDL lowering 56 stent placement 56 labetalol 56 antidiabetic medications 56 uric acid lowering 55 Defibrillation 55 oncologic outcomes 55 chemoradiation therapy 55 thiazide diuretics 55 IFN beta 55 Helicobacter pylori eradication 55 pentoxifylline 55 VT VF 55 bowel resection 55 ribavirin therapy 55 occlusive disease 55 epidural analgesia 55 beta agonists 55 transcranial Doppler 55 clopidogrel therapy 55 overt nephropathy 55 intravenous tPA 55 nocturnal hypoglycaemia 55 hyperbilirubinemia 55 antiviral therapy 55 ZYVOX 55 thyroxine 55 XIENCE V PROMUS Stent 55 serum phosphorus levels 55 pacemaker implantation 55 platelet activation 55 dopaminergic therapy 55 haemodynamic 55 oral anticoagulation therapy 55 esomeprazole 55 chronic LBP 55 caspofungin 55 cardiovascular 55 BENICAR 55 pericardial effusion 55 CRT Ds 55 urate lowering therapy 55 cytotoxic chemotherapy 55 tamsulosin 55 colorectal liver metastases 55 pulmonary artery catheterization 55 droperidol 55 tissue oxygenation 55 FVIII 55 carotid stenting 55 intravenous thrombolysis 55 nonvertebral fracture 55 CsA 55 ablative therapy 55 androgen suppression 55 atrioventricular block 55 acute coronary syndromes ACS 55 serum calcium levels 55 aspirin therapy 55 TNF inhibitor 55 cerebral perfusion 55 liver histology 55 NT proBNP 55 post operatively 55 Apidra R 55 nonrandomized 55 SERCA2a 55 trimethoprim sulfamethoxazole 55 risk stratification 55 ambulation 55 postoperatively 55 pneumonectomy 55 Liver transplantation 55 prespecified secondary 55 AVANDIA 55 Valsartan 55 REOPRO 55 antibiotic therapy 55 carvedilol 55 empiric therapy 55 aPTT 55 renoprotective 55 cardiac resynchronisation therapy 55 desvenlafaxine succinate 55 clot busting therapy 55 hyperacute 55 atrial fibrillation 55 cardiovascular morbidity 55 serum testosterone 55 anticoagulant 55 symptomatic hypotension 55 Tranexamic acid 55 MIs 55 ULORIC 55 Acute Ischemic Stroke 55 systemic corticosteroid 55 atorvastatin #mg 55 postoperative infections 55 therapeutic regimens 55 ischemic stroke 55 deferasirox 55 hypertensives 55 postop 55 lung resection 55 artery stenosis 55 myocardial infarction MI 55 FFR guided 55 ICD implants 55 #mg dose [001] 55 Apidra ® 55 APTIVUS 55 catheter insertion 55 extracorporeal membrane oxygenation 55 Cardiopulmonary bypass 55 LYSTEDA 55 stratify patients 55 intracerebral haemorrhage 55 prophylaxis 55 narrow QRS 55 transthoracic 55 blood glucose 55 aortic root replacement 55 tenecteplase 55 PASI scores 55 VAD implantation 55 improves glycemic 55 recanalization 55 intra arterial 55 rtPA 55 palliation 55 renal dysfunction 55 aspirin heparin 55 vecuronium 55 binary restenosis 55 methylprednisolone 55 idarubicin 55 ACC AHA 55 d dimer 55 FOSRENOL ® 55 acute myocardial infarction 55 rHuPH# 55 FFR guided treatment 55 oral antidiabetic medication 55 INVEGA ® 55 neostigmine 55 hematological parameters 55 preserved ejection fraction 55 QT prolongation 55 PSADT 55 transurethral resection 55 anticlotting drugs 55 HbA1C 55 carotid IMT 55 anti Xa 55 non valvular atrial 55 thrombolytic agent 55 LTRA 55 hemoglobin A1c HbA1c 55 angiotensin converting enzyme inhibitor 55 tachyarrhythmias 55 coronary bypass grafting 55 venous thromboembolism prophylaxis 55 pimecrolimus 55 sinus tachycardia 55 LVSD 55 IV bolus 55 CRT ICD 55 antihypertensive medication 55 coronary arteriography 55 hemodynamic parameters 55 ablation procedures 55 Dabigatran 55 antiepileptic drug 55 A1C levels 55 nonischemic 55 unfavorable cytogenetics 55 radiotherapy RT 55 peginterferon alfa 2a 55 olmesartan 55 coagulopathy 55 glycosylated hemoglobin HbA1c 55 rebleeding 55 glomerular filtration 55 Fully Covered Stent 55 imatinib therapy 55 liver resection 55 AF ablation procedures 55 neointimal hyperplasia 55 hyperalgesia 55 multivessel disease 55 catheter angiography 55 thrombocytopenic 55 sunitinib 55 C1 INH 55 hyperglycaemia 55 rocuronium 55 Doxil ® 55 QTc interval 55 quetiapine 55 PFO closure 55 HCTZ 55 clot busting medications 55 myocardial infarction stroke 55 cardiac biomarkers 55 PCI percutaneous coronary 55 Molecular Weight Heparin 55 acute STEMI 55 ARCOXIA 55 protamine 55 PT INR 55 triamcinolone 54 VIRAMUNE 54 metformin sulfonylurea 54 ACTOplus met 54 carotid stenosis 54 intraoperative 54 acting insulin analogues 54 transcatheter aortic valve implantation 54 diastolic heart 54 insulin lispro 54 insulin glargine 54 heparin induced thrombocytopenia 54 reteplase 54 intima media thickness 54 APTIVUS ritonavir 54 candesartan 54 INVEGA SUSTENNA 54 cinacalcet 54 tolterodine 54 IV sedation 54 lymph node dissection 54 cystectomy 54 Bivalirudin 54 dronedarone 54 Aggrastat ® tirofiban hydrochloride 54 ischemic complications 54 analgesia 54 oral antidiabetes 54 pharmacologic intervention 54 angiographic outcomes 54 hsCRP levels 54 sirolimus eluting stent 54 reintervention 54 severe exacerbations 54 Octreolin 54 inhaled budesonide 54 invasive aspergillosis 54 sustained virological response 54 glycosylated hemoglobin levels 54 co morbidities 54 cerebral vasospasm 54 renal toxicity 54 antithrombotic agent 54 liver transplant recipients 54 serum creatinine levels 54 nadolol 54 aneurysm rupture 54 Combination therapy 54 AST ALT 54 #beta estradiol 54 fragility fracture 54 hyperglycemia 54 clot busters 54 prophylactic antibiotic 54 posaconazole 54 restenosis 54 Catheter ablation 54 aromatase inhibitor therapy 54 tacrolimus 54 arterial thromboembolic events 54 ventricular arrhythmia 54 bronchodilator 54 trandolapril 54 lymphadenectomy 54 revascularizations 54 sustained virologic response 54 HoLEP 54 aspirin beta blockers 54 tachyarrhythmia 54 LV hypertrophy 54 Perforomist Inhalation Solution 54 pharmacologic stress 54 hemodynamically stable 54 hemoglobin A1c 54 PREZISTA rtv 54 serum cortisol 54 arteriography 54 adenotonsillectomy 54 perioperative morbidity 54 antiepileptic medications 54 FROVA 54 troponin T 54 ipsilateral stroke 54 exhaled nitric oxide 54 NAbs 54 doxorubicin docetaxel 54 subclinical hypothyroidism 54 LANTUS R 54 ziprasidone 54 anti arrhythmic drugs 54 liver biopsies 54 Fonarow 54 oral antiplatelet 54 CONTRAINDICATIONS 54 P = .# 54 HAART regimen 54 AF ablation 54 conventional angiography 54 tachycardias 54 antiretroviral regimen 54 antifibrinolytic 54 disease progression 54 Serum creatinine 54 octreotide LAR 54 electrophysiologic 54 pharmacological intervention 54 teriparatide 54 TAXUS stent 54 OGTT 54 recurrent ischemic 54 sentinel lymph node biopsy 54 transdermal estrogen 54 fasting plasma glucose 54 tissue perfusion 54 palivizumab 54 InterStim Therapy 54 iPTH 54 LDL C 54 intravenous bisphosphonates 54 prophylactic antibiotics 54 photocoagulation 54 intravenous sedation 54 pegfilgrastim 54 STEMI 54 coagulation 54 thromboembolic disease 54 ß blockers 54 cerebral angiography 54 OAB symptoms 54 elevated troponin 54 neoadjuvant 54 edoxaban 54 lipid lowering medications 54 eculizumab therapy 54 angiotensin converting enzyme inhibitors 54 MICARDIS ® 54 pelvic lymphadenectomy 54 carotid stents 54 VICTRELIS 54 FIRMAGON 54 metastatic RCC 54 serum creatinine 54 chemotherapeutic regimens 54 EFFEXOR XR 54 dose cytarabine 54 bisoprolol 54 SCIg 54 ischemic 54 atrial fibrillation ablation 54 pyridostigmine 54 ventricular fibrillation VF 54 biphasic insulin aspart 54 MGuard ™ 54 calculated creatinine clearance 54 asymptomatic carotid stenosis 54 aminotransferases 54 glargine 54 chlorthalidone 54 GPIIb IIIa inhibitors 54 microvascular complications 54 immunosuppressive regimens 54 EDARBI 54 infusional 54 MACCE 54 INVEGA R 54 NIHSS score 54 deferiprone 54 femoral neck fracture 54 glycoprotein IIb IIIa inhibitor 54 myopathy rhabdomyolysis 54 risedronate 54 BANZEL 54 TEVAR 54 fatal myocardial infarction 54 pegylated interferon alfa 2b 54 bypass graft CABG surgery 54 H. pylori eradication 54 levodopa therapy 54 mitral valve replacement 54 thalidomide dexamethasone 54 LANTUS ® 54 renal denervation 54 hsCRP 54 nelfinavir 54 gliclazide 54 Events MACE 54 ibandronate 54 thienopyridine 54 urinary retention 54 pulmonary capillary wedge 54 DVT PE 54 mesalamine granules 54 antiretroviral regimens 54 interferon ribavirin 54 lanthanum carbonate 54 TAVI 54 functional mitral regurgitation 54 pioglitazone Actos 54 atrial ablation 54 acute myocardial infarction AMI 54 catheterisation 54 CANCIDAS 54 cardiac 54 MEVACOR 54 PRISTIQ 54 Trasylol aprotinin 54 rivaroxaban 54 phosphate binders 54 CMV disease 54 ancrod 54 bypass grafts 54 afterload 54 atrial pacing 54 solifenacin 54 comorbidities 54 glucose lowering 54 activated partial thromboplastin 54 left ventricular systolic 54 serum phosphate 54 protease inhibitor PI 54 sirolimus stent 54 azathioprine 54 adrenalectomy 54 cardiogenic shock 54 reperfusion injury 54 micafungin 54 paroxysmal atrial fibrillation 54 atherogenic dyslipidemia 54 intravenous tissue plasminogen 54 antihypertensives 54 cystoscopic 54 immunosuppressant drug 54 ofpatients 54 QTc 54 Helixate FS 54 antiepileptic drugs AEDs 54 amikacin 54 cardioplegic arrest 54 ABVD 54 torsade de pointes 54 CMV reactivation 54 non selective NSAIDs 54 pharmacokinetic PK profile 54 transvenous 54 coronary CTA 54 Vaprisol 54 serum bilirubin 54 mL kg 54 HeartNet 54 NAVISTAR R 54 ST elevation myocardial 54 lipid parameters 54 methotrexate therapy 54 post thrombotic syndrome 54 tolerability profiles 54 MAO inhibitors 54 infliximab 54 pyrazinamide 54 epoetin 54 LNG IUS 54 failure ADHF 54 clodronate 54 pegnivacogin 54 OADs 54 AV fistulas 54 inhibit platelet function 54 macrovascular events 54 LPV r 54 bi ventricular 54 clot busting medication 54 ReoPro 54 GIK infusion 54 secondary efficacy endpoint 54 perioperative complications 53 bosentan 53 myocardial infarctions 53 orthostatic hypotension 53 rhGH 53 warfarin Coumadin 53 target vessel revascularization 53 tamoxifen therapy 53 valsartan 53 pg mL 53 postmarketing surveillance 53 riociguat 53 typical antipsychotics 53 locoregional 53 statin medications 53 decompressive surgery 53 genotypic resistance 53 PONV